Algernon Pharmaceuticals Inc. (AGN)의 가격은 얼마입니까?

Algernon Pharmaceuticals Inc. (AGN)의 가격은 $0.29357476입니다.

Algernon Pharmaceuticals Inc. (AGN)의 시가 총액은 무엇입니까?

Algernon Pharmaceuticals Inc. (AGN)의 시가 총액은 $1.02M입니다.

Algernon Pharmaceuticals Inc. (AGN) 수익

Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing new treatments. Their research and development efforts concentrate on a range of serious conditions, including non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19, operating across Canada and Australia. The company's primary drug candidate, NP-120, acts as an N-methyl-d-aspartate (NMDA) receptor glutamate antagonist. This compound specifically targets the NMDA-type subunit 2B (Glu2NB) and also demonstrates agonist activity for the Sigma-1 receptor, a chaperone protein elevated during endoplasmic reticulum stress. Furthermore, Algernon is advancing AP-188, a psychedelic agent from the tryptamine family, for treating ischemic stroke in humans. Preclinical investigations for AP-188, as part of their stroke clinical research program, are underway through a collaboration with Charles River Laboratories. Established in 2015, Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

연도	매출	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

매출

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	매출	매출 차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$10.11B	-	BE

회사

매출

매출 차이

국가